Collegium Pharmaceutical Hits Day High with 9.53% Surge in Stock Price

Collegium Pharmaceutical, Inc. experienced a notable surge today, gaining 9.53% and reaching an intraday high of USD 29.30. This performance stands in stark contrast to the S&P 500, which only saw a modest increase of 0.65% on the same day. Despite this positive movement, the stock has faced challenges over the past week, declining by 3.3%, and showing a significant drop of 19.16% over the past month. The company's market capitalization is approximately USD 1,058 million, categorizing it as a small-cap entity within the Pharmaceuticals & Biotechnology industry. Key financial metrics reveal a P/E ratio of 14.00 and a return on equity of 25.00%, indicating a relatively strong profitability per unit of equity. However, the company's ability to service its debt remains a concern, highlighted by a poor EBIT to Interest ratio of 1.55. Collegium's performance over the past year has been challenging, with a decline of 25.65%, underperforming the S&P 500, which has gained 20.6% during the same period. The stock's long-term trajectory also reflects a struggle, with a year-to-date performance down by 39.2%.